700,000,000 5.685% Senior Notes due 2026 $800,000,000 5.400% Senior Notes due 2033 Underwriting AgreementUnderwriting Agreement • March 7th, 2023 • Cigna Group • Hospital & medical service plans • New York
Contract Type FiledMarch 7th, 2023 Company Industry JurisdictionThe Cigna Group, a Delaware corporation (formerly Cigna Corporation) (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom BofA Securities, Inc., Morgan Stanley & Co. LLC and U.S. Bancorp Investments, Inc. are acting as the representatives (the “Representatives”), the aggregate principal amounts of its 5.685% Senior Notes due 2026 (the “2026 Notes”) and its 5.400% Senior Notes due 2033 (the “2033 Notes” and, collectively with the 2026 Notes, the “Notes”) listed in Schedule I to be issued pursuant to the Indenture, dated as of September 17, 2018, between the Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”) (the “Base Indenture”), as supplemented by Supplemental Indenture No. 6 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental
900,000,000 3.250% Senior Notes due 2025 Underwriting AgreementUnderwriting Agreement • March 12th, 2015 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionCigna Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amounts of its 3.250% Senior Notes due 2025 (the “Notes”) listed in Schedule I to be issued pursuant to the Indenture, dated as of August 16, 2006, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by Supplemental Indenture No. 3 thereto, dated as of March 7, 2008 (as amended, the “Base Indenture”), and Supplemental Indenture No. 9 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
300,000,000 4.500% Senior Notes due 2021 $300,000,000 5.875% Senior Notes due 2041 Underwriting AgreementUnderwriting Agreement • March 8th, 2011 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMarch 8th, 2011 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to the Indenture, dated as of August 16, 2006, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by Supplemental Indenture No. 3 thereto, dated as of March 7, 2008 (as amended, the “Base Indenture”), and Supplemental Indenture No. 7 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
250,000,000 4.375% Senior Notes due 2020 Underwriting AgreementUnderwriting Agreement • December 9th, 2010 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledDecember 9th, 2010 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to the Indenture, dated as of August 16, 2006, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by Supplemental Indenture No. 3 thereto, dated as of March 7, 2008 (as amended, the “Base Indenture”), and Supplemental Indenture No. 6 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
300,000,000 5.125% Senior Notes due 2020 Underwriting Agreement May 12, 2010Underwriting Agreement • May 28th, 2010 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMay 28th, 2010 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to the Indenture, dated as of August 16, 2006, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by Supplemental Indenture No. 3 thereto, dated as of March 7, 2008 (as amended, the “Base Indenture”), and Supplemental Indenture No. 5 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
350,000,000 8.500% Senior Notes due 2019 Underwriting Agreement May 4, 2009Underwriting Agreement • May 12th, 2009 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to the Indenture, dated as of August 16, 2006, between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by Supplemental Indenture No. 3 thereto, dated as of March 7, 2008 (as amended, the “Base Indenture”), and Supplemental Indenture No. 4 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
300,000,000 6.35% Senior Notes due 2018 Underwriting Agreement March 4, 2008Underwriting Agreement • March 10th, 2008 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMarch 10th, 2008 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to an Indenture dated as of August 16, 2006 (the “Base Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”) and Supplemental Indenture No. 3 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
250,000,000 5.375% Notes due 2017 $250,000,000 6.150% Notes due 2036 Underwriting Agreement March 12, 2007Underwriting Agreement • March 16th, 2007 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledMarch 16th, 2007 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the aggregate principal amount of its notes listed in Schedule I (the “Notes”) to be issued pursuant to an Indenture dated as of August 16, 2006 (the “Base Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”) and Supplemental Indenture No. 1 to the Base Indenture entered into and Supplemental Indenture No. 2 to be entered into between the Company and the Trustee (the “Supplemental Indentures,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.
Underwriting Agreement November 7, 2006Underwriting Agreement • November 14th, 2006 • Cigna Corp • Hospital & medical service plans • New York
Contract Type FiledNovember 14th, 2006 Company Industry JurisdictionCIGNA Corporation, a Delaware corporation (the “Company”), confirms, subject to the terms and conditions stated herein, its agreement to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) $250,000,000 aggregate principal amount of its 6.150% Notes due 2036 (the “Notes”) to be issued pursuant to an Indenture dated as of August 16, 2006 (the “Base Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”) and a Supplemental Indenture No. 1 to the Base Indenture to be entered into between the Company and the Trustee (the “Supplemental Indenture,” and together with the Base Indenture and any amendments or supplements thereto, the “Indenture”), between the Company and the Trustee.